We provide you with 20 years of free, institutional-grade data for PSTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PSTX. Explore the full financial landscape of PSTX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Poseida Therapeutics, Inc(NASDAQ:PSTX) 
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company is developing P-BCMA-101, an autologous chimeric antigen receptor T cell (CAR-T) targeting B cell maturation antigen that is in Phase II ...
Website: http://www.poseida.com
Founded: 2014
Full Time Employees: 186
CEO: Eric M. Ostertag
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about PSTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.